It’s difficult to educate others when the local paeds ER is prescribing bronchodilators for bronchiolitis for 6 month olds. https://t.co/cNGlmfwOD3
Bronchodilators for bronchiolitis.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jan 2019 – May 2024Where it's discussed
-
News23 articles
-
X / Twitter17 posts
-
Facebook9 posts
-
Blogs4 articles
-
YouTube1 videos
AI synopsis
What people are saying
The overall sentiment reflects consensus around the evidence-based stance that bronchodilators do not improve meaningful outcomes in bronchiolitis, with posts citing specific research such as the Cochrane review and clinical experiences that emphasize the gap between evidence and practice. The tone is analytical and practical, illustrating both scientific validation and real-world implications for pediatric care.
Most discussions agree that bronchodilators lack evidence of benefit and are not recommended by current guidelines.
Participants show moderate interest, referencing specific studies and clinical practices, indicating engagement with the topic.
Posts involve sharing research references and clinical experiences, demonstrating a genuine engagement beyond surface-level discussion.
The discussions highlight ongoing challenges in changing clinical practice, implying some influence of the publication on clinical decision-making.
Abstract in brief
- Bronchodilators do not significantly improve oxygen saturation, reduce hospitalization rates, or shorten hospital stays in infants with bronchiolitis, whether treated as outpatients or inpatients.
- The analyzed trials showed minimal to no benefit in clinical scores, with slight improvements in outpatient clinical scores that may not be clinically meaningful.
- Overall, the evidence suggests that bronchodilators are not effective for treating bronchiolitis in infants and may not significantly impact key clinical outcomes.
Top posts
Most liked on X and Bluesky@Dr_ScottK @DocEMurray @BetaMomma @DeannaMarie208 @DrCJohns @MrsDrMonty @sgdambrauskas @SapnaKmd And it won't change their clinical course... https://t.co/GPqFYwsnd4
Should We Use Bronchodilators for Bronchiolitis? https://t.co/RW2lRqdSgD #FOAMed
@paedsem @gracie_leo Predict and the predict reference list seem a good place to start. For more Ventolin specific stuff : Gadomski AM, Scribani MB. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev. 2014;6:CD001266
https://t.co/1nDEjfewVB #FOAMed #FOAMped #FOAMems
Bronchodilators for bronchiolitis? Choose wisely - there is no evidence that even a transient benefit will lead to improved outcomes #medtwitter #choosingwisely https://t.co/aqGb42281m
All mentions
Managing Respiratory Compromise in RSV During Pandemic Immunity Gap
The Pandemic Immunity Gap is likely behind the massive surge in respiratory syncytial virus RSV with current CDC data showing a 275 increase from 20202021 to 20222023. Join Eric for a deep dive into a case study…
6/7) Entonces, la bronquiolitis es una enfermedad heterogénea y, en consecuencia, su tratamiento debería ser variable. Pero la dogmática “medicina basada en evidencia” señala que los broncodilatadores no tienen un sitio en el tratamiento. https://t.co/H89AzM8vaL https://t.co/zjvKLVChJw
Should We Use Bronchodilators for Bronchiolitis? https://t.co/pHNNBHkanl
Should We Use Bronchodilators for Bronchiolitis? https://t.co/apKNcz05tP
RT @spoonfedEM: Should We Use Bronchodilators for Bronchiolitis? https://t.co/RW2lRqdSgD #FOAMed
RT @jgollw: https://t.co/1nDEjfewVB #FOAMed #FOAMped #FOAMems
RT @jgollw: https://t.co/1nDEjfewVB #FOAMed #FOAMped #FOAMems
https://t.co/1nDEjfewVB #FOAMed #FOAMped #FOAMems
Should We Use Bronchodilators for Bronchiolitis? https://t.co/RW2lRqdSgD #FOAMed
@Dr_ScottK @DocEMurray @BetaMomma @DeannaMarie208 @DrCJohns @MrsDrMonty @sgdambrauskas @SapnaKmd And it won't change their clinical course... https://t.co/GPqFYwsnd4
Maybe this is an #implementation issue? A flag for something that seems to be a barrier in practice? Here’s a start for clinicians Gadomski AM, Scribani MB. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev. 2014;(6):CD001266. 2/2
Bronchodilators for bronchiolitis? Choose wisely - there is no evidence that even a transient benefit will lead to improved outcomes #medtwitter #choosingwisely https://t.co/aqGb42281m
RT @Kidsdoc1Rick: It’s difficult to educate others when the local paeds ER is prescribing bronchodilators for bronchiolitis for 6 month old…
RT @Kidsdoc1Rick: It’s difficult to educate others when the local paeds ER is prescribing bronchodilators for bronchiolitis for 6 month old…
It’s difficult to educate others when the local paeds ER is prescribing bronchodilators for bronchiolitis for 6 month olds. https://t.co/cNGlmfwOD3
@paedsem @gracie_leo Predict and the predict reference list seem a good place to start. For more Ventolin specific stuff : Gadomski AM, Scribani MB. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev. 2014;6:CD001266
@JLRohmann @kaz_yos Bronchodilators for bronchiolitis in children.
@1689Ranger @XianJaneway This is why they didn't give albuterol: "Bronchodilators such as albuterol do not improve oxygen saturation, reduce hospital admission after outpatient treatment, shorten the duration of hospitalization or reduce the time to resolution of illness at home" https://t.co/pUGE6CTTHe
RM
CM
CS
BS
G
TH
HC
GF
EI
M
BW
FH
MS
D
R
KT
SD